We are pleased to announce that a leading expert in the field of developmental and reproductive toxicology (DART), and juvenile toxicology—Dr. Gregg Cappon—has joined ToxStrategies’ staff. Together with Dr. John Rogers and Dr. Sara Hershberger, our staff’s diverse experience offers end-to-end support to address your product development needs. From fit-for-purpose testing strategies through protocol development, study oversight, and interpretation of study data, to risk management and regulatory interactions, ToxStrategies is a one-stop shop for expertise in DART and juvenile toxicology.
Dr. Gregg Cappon is a pharmacological toxicologist who brings more than 25 years of experience in the pharmaceutical industry. His expertise focuses on nonclinical safety assessment and drug development, with an emphasis on reproductive toxicology and pediatric drug development. He has managed organizations of up to 34 scientists in designing and conducting studies to support drug development candidates, internal and external study conduct, preparation of regulatory submission, and responding to regulatory queries. In addition to management responsibilities, he has experience as a drug development project team representative, affording him broad knowledge of drug development and regulatory strategies, including vaccines, nonalcoholic steatohepatitis (NASH), dermatology, pain, osteoporosis, and various metabolic and central nervous system (CNS) conditions. Dr. Cappon has provided project team support at all stages of the drug development process, from discovery research to investigational new drug (IND) submission, through early and late clinical development, to marketing authorization.
Dr. Cappon is based in East Lyme, Connecticut, and can be reached by phone at 860-276-7310, or by e-mail at gcappon@toxstrategies.com.
Dr. John Rogers is a Senior Consultant in ToxStrategies’ Health Sciences Practice. He is a widely recognized authority on developmental and reproductive toxicology. Over 35 years, his work has included dose-response assessment of developmental toxicity, elucidating mechanisms of abnormal development, building biologically based dose-response models and adverse outcome pathways, assessing the role of maternal toxicity in adverse developmental outcomes, epigenetics and the developmental origins of health and disease. He has studied the developmental toxicity of pesticides, fungicides, industrial chemicals, and pharmaceuticals. Recently, he organized symposia on the development of new alternative (animal-free) methods (NAMs) for developmental toxicity assessment. Dr. Rogers enters the consulting arena following a long and distinguished career with the US EPA’s Office of Research and Development, during which he received nine professional society and academic awards and fourteen scientific and technical achievement awards. He has also held adjunct faculty appointments at the University of North Carolina and NC State University.
Dr. Rogers is based in Raleigh, North Carolina, and can be reached by phone at 919-306-1996, or by e-mail at jrogers@toxstrategies.com.